MedTrace Logo

Trial of Vitamin D Supplementation for the Prevention of Influenza and Other Respiratory Infections (ViDiFlu)

NCT01069874 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2014-02-04

No results posted yet for this study

Summary

Purpose: The study null hypothesis is that vitamin D supplementation will not influence time to acute respiratory tract infection in sheltered accommodation residents.

Conditions

Interventions

DIETARY_SUPPLEMENT

Cholecalciferol (Vitamin D/Vigantol oil)

Cholecalciferol will be administered as 2-monthly oral bolus doses of Vigantol oil over a period of one year

DIETARY_SUPPLEMENT

Miglyol oil

Miglyol oil will be administered as 2-monthly oral bolus doses of Miglyol oil over a period of one year

Sponsors & Collaborators

  • National Health Service, United Kingdom

    collaborator OTHER_GOV

  • Barts & The London NHS Trust

    lead OTHER

Principal Investigators

  • Adrian R Martineau, MRCP · Queen Mary University of London

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01069874 on ClinicalTrials.gov